Skip to main content

Table 1 Baseline characteristics of the HIV group and the comparison group

From: Risk of cancer among HIV-infected patients from a population-based nested case–control study: implications for cancer prevention

Variable HIV Patients (n = 1,115) Control (n = 4,460)  
No. (%) No. (%) P-value
Age    1
24 137 (12.3) 548 (12.3)  
 25 – 44 626 (56.1) 2,504 (56.1)  
 45 – 64 202 (18.1) 808 (18.1)  
65 150 (13.5) 600 (13.5)  
Gender    1
 Male 836 (75) 3,344 (75)  
 Female 279 (25) 1,116 (25)  
Monthly income    <0.001
 NTD 0 ~ 17280 502 (45) 1,355 (30.4)  
 NTD 17281 ~ 28800 399 (35.8) 1,624 (36.4)  
 NTD ≥28801 279 (19.2) 1481 (33.2)  
Urbanization level    <0.001
 1 355 (31.8) 1,291 (29)  
 2 313 (28.1) 1,412 (31.7)  
 3 210 (18.8) 891 (20)  
 4 139 (12.5) 538 (12.1)  
 5 22 (2) 78 (1.8)  
 6 35 (3.1) 126 (2.8)  
 7 41 (3.7) 124 (2.8)  
Modified Charlson score    <0.001
 0 29 (2.6) 1,644 (36.8)  
 1-5 1011 (90.7) 2638 (59.2)  
6 75 (6.7) 184 (4.1)  
Mean follow-up time (months) 55.53 56.12  
  SD 38.70 36.96  
  Q1 26.73 26.9  
  Q3 76.98 73.73  
Cancer 104 (9.3) 119 (2.7) <0.001
  1. Modified Charlson index: Charlson index excluding HIV/AIDS, malignancy.
  2. SD: standard deviation.
  3. Q1: first interquartile, Q3: third interquartile.
\